Prediction of adjuvant chemotherapy benefit in endocrine responsive, early breast cancer using multigene assays.

Publication Name: The Breast

Author(s): Kathy S Albain, Soonmyung Paik, Laura van ’t Veer

Background: Multigene assays performed on the primary tumors from women with non- metastatic breast cancer provide useful prognostic information and discriminate excellent versus poor outcome potential in diverse clinical scenarios. Recently, analyses were conducted to determine if these assays predict … Continued